Commonwealth Numbered Regulations
[Index]
[Table]
[Search]
[Search this Regulation]
[Notes]
[Noteup]
[Previous]
[Download]
[Help]
1980 No. 338 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 5
SCHEDULE 5
Sub-regulations 14 (1) and (2), paragraphs 19 (1) (h) and 21 (1) (e) and
sub-regulation 22 (2) PRESCRIBING OF PHARMACEUTICAL BENEFITS SUBJECT TO
CONDITIONS AND
RESTRICTIONS
------------------------------------------------------------------------------
-- Column 1 Column 2 Column 3
Classes of persons, diseases, &c.,
purposes and conditions
Item Pharmaceutical benefit specified in relation to the
pharmaceutical benefit
------------------------------------------------------------------------------
-- 1 Acetylcysteine . . . . . . Bronchiectasis
Cystic fibrosis (mucoviscidosis)
2 Acrylic Resin . . . . . . . Ileostomy or colostomy conditions
3 Amantadine Hydrochloride . The treatment of Parkinson's disease
caused otherwise than by treatment with a drug
4 (1) Aminocaproic Acid,
B.P. . . . . . . . . . . . Treatment in hospital of patients
suffering from severe haemorrhage
associated with excessive fibrinolysis
(2) Aminocaproic, Acid
Injection, B.P.
5 "AMINOGRAN MINERAL MIXTURE" Phenylketonuria 6 Ascorbic
Acid Tablets, B.P. Any disease or condition in a pensioner
7 Atenolol . . . . . . . . . Hypertension
8 Azathioprine Tablets, B.P. Any disease or condition in a patient
receiving treatment in or at an approved
hospital
With the written authority of the
Permanent Head-
Anaemia, autoimmune haemolytic
Arthritis, rheumatoid with vasculitis or visceral complications
Continuing azathioprine therapy after
discharge from a hospital
Crohn's disease
Dermatomyositis
Granulomatosis, Wegener's
Hepatitis, active, chronic
Lupus erythematosus, systemic
Nephritis
Nephrotic syndrome
Organ transplant
Pemphigus
Polyarteritis nodosa
Pyoderma gangrenosum
Scleroderma
Thrombocytopenic purpura
Ulcerative colitis
9 Baclofen . . . . . . . . . With the written authority of the
Permanent Head-Spasticity due to multiple sclerosis or spinal cord lesions
10 "BANISH" . . . . . . . . Ileostomy or colostomy conditions 11
Beclomethasone Dipropionate
Metered Aerosol Spray Chronic intractable asthma requiring
maintenance corticosteroids
12 Benzoin Compound Tincture,
B.P.C., Aerosol Spray Ileostomy or colostomy conditions
13 Betamethasone Acetate with
Betamethasone Injection Alopecia areata
Granulomata, dermal
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Local intra-articular or peri-articular
infiltration
Lupus erythematosus, chronic discoid
Necrobiosis lipoidica
Uveitis
14 Bisacodyl Suppositories,
B.P. . . . . . . . . . . . Any disease or condition in a
paraplegic
or quadriplegic patient
For use by patients who are receiving
long-term intensive nursing care in
hospitals or nursing homes
For use by patients for whose care a
Commonwealth Domiciliary Nursing Care
Benefit is approved
15 Bleomycin Sulphate . . . . Choriocarcinoma of the testis
Embryonal cell carcinoma of the testis
Lymphoma
Squamous cell carcinoma
16 Butyl Monoester Polymer
with Isopropyl Alcohol Ileostomy or colostomy conditions
17 (1) Calciferol, B.P. . . . With the written authority of the
Permanent Head-
(2) Calciferol Tablets,
Strong, B.P. . . . . . . . Hypocalcaemia
Hypoparathyroidism
Osteomalacia following gastrectomy,
severe steatorrhoea or renal failure
Vitamin D-resistant rickets
18 Calcium Carbonate, B.P.,
with Calcium
Lactate-Gluconate With the written authority of the
Permanent Head-
Hypocalcaemia
Osteoporosis
19 Calcium Carbonate, B.P.,
with Citric Acid
Monohydrate, B.P., Compound
Effervescent Tablets With the written authority of the
Permanent Head-
Hypocalcaemia
Osteoporosis
20 Calcium Folinate . . . . . Antidote to folic acid antagonists
21 Carbenicillin Sodium . . . Any disease or condition in a patient
receiving treatment in or at an approved
hospital
Infections where positive bacteriological evidence confirms that carbenicillin
is
the most appropriate therapeutic agent
Septicaemia, suspected or proven
22 Carbenoxolone Tablets, B.P. Gastric ulcer where a radiological
examination or other tests have confirmed the presence of a gastric ulcer
23 (1) Cephalexin Capsules,
B.P. . . . . . . . . . . . Any disease or condition in a patient
receiving treatment in or at an approved
hospital
(2) Cephalexin, B.P., with
Purified Water, B.P. With the written authority of the
Permanent Head-
Infections where positive
bacteriological evidence confirms that
cephalexin monohydrate is the most
appropriate therapeutic agent
24 Cephaloridine . . . . . . . Endophthalmitis
Infections where positive bacteriological evidence confirms that cephaloridine
is
the most appropriate therapeutic agent
25 Cephalothin Sodium . . . . Infections where positive
bacteriological evidence confirms that cephalothin sodium is the most
appropriate therapeutic agent 26 Cephazolin Sodium . . . . . Infections
where positive bacteriological evidence confirms that cephazolin sodium
is the most appropriate therapeutic
agent 27 (1) Cephradine Capsules . . With the written authority of the
Permanent Head-
(2) Cephradine with
Purified Water, B.P. Infections where positive
bacteriological evidence confirms that
cephradine is the most appropriate
therapeutic agent
28 Cephradine for Injection . Infections where positive
bacteriological evidence confirms that cephradine is the
most appropriate therapeutic agent
29 Charcoal Tablets . . . . . Ileostomy or colostomy conditions
30 Chlorambucil Tablets, B.P. Any disease or condition in a patient
receiving treatment in or at an approved
hospital
With the written authority of the
Permanent Head-
Anaemia, autoimmune, haemolytic
Arthritis, rheumatoid with vasculitis or visceral complications
Continuing chlorambucil therapy after
discharge from a hospital
Crohn's disease
Dermatomyositis
Granulomatosis, Wegener's
Hepatitis, active chronic
Lupus erythematosus, systemic
Malignant disease including leukaemia
Nephritis
Nephrotic syndrome
Polyarteritis nodosa
Scleroderma
Thrombocytopenic purpura
Ulcerative colitis
31 Chloramine Deodorant
Tablets and Powder Ileostomy or colostomy conditions
32 (1) Chloramphenicol
Capsules, B.P. Bacterial meningitis
(2) Chloramphenicol Sodium
Succinate for Injection Intraocular infections
Rickettsioses
(3) Chloramphenicol
Palmitate Oral Suspension Typhoid
The treatment of other serious infections in a patient where it is established
by
appropriate bacteriological testing that
chloramphenicol is the only suitable
antibiotic listed as a pharmaceutical
benefit for use in treating the infection in the patient
33 Chlormethiazole . . . . . . With the written authority of the
Permanent Head-
Short-term alcohol or drug withdrawal
therapy in a hospital or approved centre
Status epilepticus
34 Chlormethiazole Edisylate . Short-term alcohol or drug withdrawal
therapy in a hospital or approved centre
Status epilepticus
35 Chlorotrianisene Tablets . Carcinoma of the prostate
36 (1) Chlorpromazine
Hydrochloride, B.P. Chorea
Hyperactive states of organic or toxic
delirium
(2) Chlorpromazine
Injection, B.P. . . . . . . Major psychoses including-
(3) Chlorpromazine Tablets,
B.P. . . . . . . . . . . . Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who
have not attained the age of 16 years
37 Cholestyramine . . . . . . With the written authority of the
Permanent Head-
Bile salt malabsorption associated with
ileal resection or proven ileal disease
Pruritus associated with partial biliary obstruction not responding to other
therapy
Treatment of hypercholesterolaemia
38 Cimetidine . . . . . . . . With the written authority of the
Permanent Head-
Duodenal ulcer, confirmed by radiology,
endoscopy or surgery
Gastric ulcer, confirmed by radiology,
endoscopy or surgery
Zollinger-Ellison syndrome, proven by
investigation
39 (1) Clindamycin
Hydrochloride . . . . . . . Gram-positive coccal infections where
the infection cannot be safely and
effectively treated with penicillin or a
derivative of penicillin
(2) Clindamycin Palmitate
Hydrochloride
39A Clofibrate Capsules, B.P. . With the written authority of the
Permanent Head-
Severe resistant type III
hyperlipidaemia proven by laboratory
report and not responding to adequate
dietary therapy
Proven severe endogenous type IV or type V hyperlipidaemia not responding to
adequate dietary therapy
40 Clonazepam . . . . . . . . Epilepsy
41 (1) Cloxacillin Capsules,
B.P. Any disease or condition in a patient
receiving treatment in or at an approved
hospital
(2) Cloxacillin Sodium,
B.P., with Purified Water,
B.P. With the written authority of the
Permanent Head-
Infections due to the presence of
penicillin-resistant staphylococci
Osteomyelitis
42 Codeine Phosphate with
Aspirin, Soluble Tablets Any disease or condition in a
pensioner
43 Codeine Phosphate with
Aspirin and Paracetamol
Tablets, 30mg-225mg-150mg
tablets Malignant neoplasia
44 Colistin Sulphomethate
Sodium, B.P., for injection Pyocyaneus infection, other
gram-negative infections where no other drug is
effective
45 Cyanocobalamin Injection,
B.P. Pernicious anaemia and other proven
Vitamin B12 deficiencies
Post-gastrectomy treatment
Sub-acute combined degeneration of the
cord
46 (1) Cyclophosphamide, B.P. Any disease or condition in a patient
receiving treatment in or at an approved
hospital
(2) Cyclophosphamide
Tablets, B.P. With the written authority of the
Permanent Head-
Anaemia, autoimmune, haemolytic
Arthritis, rheumatoid with vasculitis or visceral complications
Continuing cyclophosphamide therapy
after discharge from a hospital
Crohn's disease
Dermatomyositis
Granulomatosis, Wegener's
Hepatitis, active, chronic
Lupus erythematosus, systemic
Malignant disease, including leukaemia
Nephritis
Nephrotic syndrome
Pemphigus
Polyarteritis nodosa
Scleroderma
Thrombocytopenic purpura
Ulcerative colitis
47 Danazol . . . . . . . . . . With the written authority of the
Permanent Head-
Endometriosis, proven by visual means
Hereditary angio-oedema
48 "DE-LACT INFANT" . . . . Acute gastro-enteritis, complicated by
lactose intolerance in infants under the
age of six (6) months
49 Deodorant Detergent
Solution
(Lauryldimethylbenzyl
Ammonium Chloride and
"TERIC N8") Any disease or condition in a paraplegic
or quadriplegic patient
Ileostomy or colostomy conditions
50 Dexamethasone Sodium
Phosphate Injection
equivalent of
Dexamethasone Phosphate
120 mg in 5 ml For use in a hospital
51 Dexamphetamine Tablets,
B.P. With the written authority of the
Permanent Head-
For the treatment of a patient who has
not attained the age of 21 years and who
is hyperkinetic as a result of brain
damage
Narcolepsy
52 (1) Dextromoramide
Tablets, B.P. Treatment in malignant neoplasia
(2) Dextromoramide
Tartrate, B.P.
53 Dicyclomine Hydrochloride
with Doxylamine Succinate
and Pyridoxine
Hydrochloride Vomiting in pregnancy
54 "DIGESTELACT" . . . . . . With the written authority of the
Permanent Head-
Lactose intolerance
55 Dihydrotachysterol . . . . With the written authority of the
Permanent Head-
Hypoparathyroidism
Osteomalacia following gastrectomy,
severe steatorrhoea or renal failure
Vitamin D-resistant rickets
56 Dimethicone Aerosol Spray . Ileostomy or colostomy conditions
57 Dimethicone Creams . . . . Any disease or condition in a
paraplegic
or quadriplegic patient
Use with surgical appliances
58 (1) Dioctyl Sodium
Sulphosuccinate Any disease or condition in a
paraplegic
or quadriplegic patient
(2) Dioctyl Sodium
Sulphosuccinate with
Bisacodyl For use by patients who are receiving
long-term intensive nursing care in
hospitals or nursing homes
(3) Dioctyl Sodium
Sulphosuccinate with
Danthron For use by patients for whose care a
Commonwealth Domiciliary Nursing Care
Benefit is approved
59 Diphemanil Methylsulphate . Amputees
Any disease or condition in a paraplegic
or quadriplegic patient
60 Dipyridamole . . . . . . . With the written authority of the
Permanent Head-
Supplementing anticoagulants in-
Biopsy proven glomerulonephritis
Microangiopathic renal disease
Renal allograft
Patients with cardiac prosthesis
61 (1) Disopyramide . . . . . Cardiac arrhythmias, when other
anti-arrhythmic drug therapy is
unsatisfactory
(2) Disopyramide Phosphate
62 Ethacrynic Acid Tablets,
B.P. . . . . . . . . . . . Patients who are hypersensitive to
other
oral diuretics
63 Ethyloestrenol Tablets,
B.P. . . . . . . . . . . . With the written authority of the
Permanent Head-
Osteoporosis
Patients on long-term treatment with
corticosteroids
64 Flucytosine . . . . . . . . Invasive or systemic fungal infections
such as candidiasis, cryptococcosis and
chromoblastomycosis
65 Fluoxymesterone Tablets,
B.P. . . . . . . . . . . . With the written authority of the
Permanent Head-
Aplastic anaemias, proven
Carcinoma of the breast
Hypogonadism
Osteoporosis
66 (1) Fluphenazine Decanoate
Injection, B.P. Chorea
Hyperactive states of organic or toxic
delirium
(2) Fluphenazine Enanthate
Injection, B.P. Major psychoses including-
Major organic psychoses including
arteriopathic dementia
(3) Fluphenazine
Hydrochloride, B.P. Manic-depressive psychosis
(4) Fluphenazine Tablets,
B.P. . . . . . . . . . . . Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
67 Fosfestrol Tetrasodium . . Carcinoma of the prostate
68 Frusemide Tablets, B.P.,
500 mg . . . . . . . . . . Renal failure
69 Fusidic Acid . . . . . . . Any disease or condition in a patient
receiving treatment in or at an approved
hospital
With the written authority of the
Permanent Head-
For use in combination with another
antibiotic in the treatment of serious
staphylococcal infections confirmed by
bacteriological evidence
70 "GALACTOMIN FORMULA No. 17" With
the written authority of the Permanent
Head-
Galactosaemia
Conditions needing an extreme
restriction of lactose in the diet of a
patient who has not attained the age of 4 years
71 "GALACTOMIN FORMULA No. 19" With
the written authority of the Permanent
Head-
Glucose-galactose malabsorption
72 Gentamicin Injection, B.P. Any disease or condition in a patient
receiving treatment in or at an approved
hospital
With the written authority of the
Permanent Head-
Endophthalmitis
Infections where positive
bacteriological evidence confirms that
gentamicin sulphate is the most
appropriate antibiotic
Septicaemia including suspected
septicaemia
73 "GLUCOSE NUTRAMIGEN" . . With the written authority of the
Permanent Head-
Cows' milk allergy in children who have
not attained the age of 2 years
Cystic fibrosis (mucoviscidosis)
Galactosaemia
Lactose intolerance
74 Glycerol Suppositories,
B.P. . . . . . . . . . . . Any disease or condition in a
paraplegic
or quadriplegic patient
For use by patients who are receiving
long-term intensive nursing care in
hospitals or nursing homes
For use by patients for whose care a
Commonwealth Domiciliary Nursing Care
Benefit is approved
75 Griseofulvin Tablets, B.P. With the written authority of the
Permanent Head-
For use in recalcitrant tinea infections due to Microsporum, Trichophyton or
Epidermophyton species proven by
pathology testing, or, in the case of the scalp, by pathology testing or by
Wood's
Light examination
Kerion
76 (1) Haloperidol . . . . . Chorea
(2) Haloperidol Tablets,
B.P. . . . . . . . . . . . Hyperactive states of organic or toxic
delirium
Malignant neoplasia (late stage)
Radiation sickness
Major psychoses including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
77 Hydrocortisone Acetate
Injection, B.P. Alopecia areata
Granulomata, dermal
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Local intra-articular or peri-articular
infiltration
Lupus erythematosus, chronic discoid
78 Hydrocortisone Sodium
Succinate Injection, 500 mg Any disease or condition in a patient
receiving treatment in a hospital
79 (1) Idoxuridine Eye Drops Eye infections caused by Herpes
Simplex
Virus or by Vaccinia Virus
(2) Idoxuridine Eye
Ointment
80 Influenza Vaccine . . . . . For prophylaxis of persons at special
risk of adverse consequences from
infections of the lower respiratory
tract 81 (1) Insulin Injection
Biphasic Specially Purified Insulin resistance, insulin allergy,
disabling local reactions or atrophy
Juvenile diabetes
(2) Insulin Injection,
Neutral Specially Purified Patients already stabilised on this
type
of insulin
(3) Insulin Isophane
Injection, Specially
Purified, and Insulin
Injection, Neutral
Specially Purified
(4) Insulin Isophane
Injection Specially
Purified-Porcine
(5) Insulin Zinc
Suspension Specially
Purified Injection
(6) Insulin Zinc
Suspension (Amorphous)
Specially Purified
Injection
(7) Insulin Zinc
Suspension (Crystalline)
Specially Purified
Injection
82 "ISOMIL" . . . . . . . . With the written authority of the
Permanent Head-
Cows' milk allergy in children who have
not attained the age of 2 years
Galactosaemia
Homocystinuria
Lactose intolerance
83 Isopropyl Monoester Polymer
with Isopropyl Alcohol B.P. Ileostomy or colostomy conditions
84 Kanamycin Injection, B.P. . Infections where positive
bacteriological evidence confirms that kanamycin sulphate is the most
appropriate antibiotic
Septicaemia, including suspected
septicaemia
85 (1) "KETOVITE" Liquid . With the written authority of the
Permanent Head-
(2) "KETOVITE" Tablets . Galactosaemia Persistent monosaccharide
intolerance
Phenylketonuria
Tyrosinosis (hereditary)
86 Lactulose . . . . . . . . . Hepatic coma or pre-coma (chronic
portosystemic encephalopathy)
87 Lincomycin Injection, B.P. Gram-negative anaerobic infections
Gram-positive coccal infections where
these cannot be safely and effectively
treated with penicillin or a derivative
of penicillin
88 "LOCASOL" . . . . . . . . With the written authority of the
Permanent Head-
Hypercalcaemia in children who have not
attained the age of 2 years
Osteopetrosis
89 Mafenide Acetate . . . . . With the written authority of the
Permanent Head-
Treatment, in a hospital, of burns
Treatment, in a hospital, of
epidermolysis bullosa
90 Medroxyprogesterone Acetate
Injections, 50 mg in 1 ml Malignant neoplasia
91 Medroxyprogesterone Acetate
Injections, 150 mg in 1 ml Malignant neoplasia
Precocious puberty
92 Medroxyprogesterone Acetate
Tablets, 2.5 mg Dysfunctional uterine bleeding
Precocious puberty
Turner's syndrome
93 Medroxyprogesterone Acetate
Tablets, 10 mg Dysfunctional uterine bleeding
Malignant neoplasia
Precocious puberty
Turner's syndrome
94 Medroxyprogesterone Acetate
Tablets, 100 mg Malignant neoplasia
95 (1) Metformin
Hydrochloride, B.P.
(2) Metformin Tablets,
B.P. Maturity onset diabetes not
satisfactorily controlled by diet and
other drugs, where the risk of lactic
acidosis is minimised by excluding
predisposing factors, especially reduced
renal, hepatic or cardiovascular
function 96 (1) Methadone Injection,
B.P. Disabling pain associated with proven
malignant neoplasia
(2) Methadone Tablets,
B.P. . . . . . . . . . . . Disabling pain associated with
self-limiting disorders of short duration not responding to non-narcotic
analgesics, the maximum duration of
treatment being two weeks
97 (1) Methandienone Tablets,
B.P. . . . . . . . . . . . With the written authority of the
Permanent Head-
Osteoporosis
(2) Methenolone Acetate . Patients on long-term treatment with
corticosteroids
98 Methicillin Sodium, B.P.,
for injection Endophthalmitis
Proven or suspected staphylococcal
septicaemia
99 (1) Methotrexate Injection Any disease or condition in a patient
receiving treatment in or at an approved
hospital
(2) Methotrexate Tablets . With the written authority of the
Permanent Head-
Continuing methotrexate therapy after
discharge from a hospital
Malignant neoplasia
Pemphigus
Severe intractable or extensive
psoriasis
100 Methylphenobarbitone . . . Epilepsy
101 Methylprednisolone Acetate
Injection, B.P. For local intra-articular or
peri-articular infiltration
102 Methyltestosterone Tablets,
B.P., 5 mg Hypogonadism in patients who have not
attained the age of 16 years
103 Methyltestosterone Tablets,
B.P., 25 mg or 50 mg Carcinoma of the breast
Hypogonadism
Klinefelter's syndrome (seminiferous
tubule dysgenesis)
104 Methysergide Tablets . . . Carcinoid syndrome
Prevention of disabling migraine when
other treatment has failed
105 Metoclopramide
Hydrochloride, B.P., 10 mg
Tablets With the written authority of the
Permanent Head-
Gastric retention after gastric surgery
Malignant neoplasia (late stage)
106 Metoprolol Tartrate . . . . Frequent disabling angina without
evidence of cardiac failure
Hypertension
107 Mithramycin . . . . . . . . For use in a hospital for-
Inoperable testicular neoplasm
Symptomatic hypercalcaemia and
hypercalcinuria associated with advanced
neoplasia
108 Morphine Sulphate, B.P.,
with Tacrine Hydrochloride
Tablets Severe intractable pain
109 Nandrolone Decanoate
Injection, B.P. With the written authority of the
Permanent Head-
Carcinoma of the breast
Osteoporosis
Patients on long-term treatment with
corticosteroids
110 Nandrolone Phenylpropionate
Injection, B.P. With the written authority of the
Permanent Head-
Carcinoma of the breast
Osteoporosis
Patients on long-term treatment with
corticosteroids
111 Neomycin Tablets, B.P. . . Acute leukaemia during induction of
remission with chemotherapy
Bowel sterilisation preparatory to major
surgery
Encephalopathy, hepatic
Enteropathogenic E. coli infections in
infants
112 Nicotinic Acid Tablets,
B.P. . . . . . . . . . . . Any disease or condition in a
pensioner
113 (1) Nitrofurantoin, B.P. . Urinary tract infections by organisms
where sulphonamide treatment has proved
ineffective and positive bacteriological
evidence confirms that the organisms are
sensitive to nitrofurantoin, or where the patient is sensitive to
sulphonamides
(2) Nitrofurantoin
Tablets, B.P.
114 Norethisterone Acetate,
B.P., Tablets, 10 mg Malignant neoplasia
115 Norethisterone Acetate,
B.P., Tablets, 2.5 mg Dysfunctional uterine bleeding
Endometriosis
Precocious puberty
Turner's syndrome
116 Norethisterone Tablets,
B.P., 5 mg Benign mammary dysplasia
Dysfunctional uterine bleeding
Endometriosis
Precocious puberty
Turner's syndrome
117 Orphenadrine Hydrochloride
Tablets, B.P. Parkinsonism
118 Oxycodone Hydrochloride . . Treatment in malignant neoplasia
119 Oxymetholone Tablets, B.P. With the written authority of the
Permanent Head-
Proven aplastic anaemias
Myelosclerosis
120 (1) Pancreatin Enzyme 4X
U.S.N.F. XIII strength Cystic fibrosis (mucoviscidosis)
Following pancreatico-duodenectomy
(2) Pancreatin Enzyme 5X
U.S.N.F. XIV strength Pancreatic steatorrhoea
(3) Pancrelipase . . . . .
121 (1) Penicillamine B.P. . . With the written authority of the
Permanent Head-
(2) Penicillamine
Capsules, B.P. . . . . . . Acute heavy metal intoxication
(3) Penicillamine Tablets,
B.P. . . . . . . . . . . . Cystinosis
Cystinuria with calculus formation
For the continuing treatment of
rheumatoid arthritis where penicillamine
therapy was initiated in a hospital
Haemoglobinuria, paroxysmal cold
Wilson's disease (hepatolenticular
degeneration)
122 Pentazocine Lactate
Injection, B.P. . . . . . . Disabling pain associated with proven
malignant neoplasia
Disabling pain associated with
self-limiting disorders of short duration not responding to non-narcotic
analgesics, the maximum duration of
treatment being two weeks
123 Perhexiline Maleate . . . . With the written authority of the
Permanent Head-
Intractable angina not responding to
other therapy
124 Pericyazine . . . . . . . . Chorea
Hyperactive states of organic or toxic
delirium
Major psychoses, including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who
have not attained the age of 16 years
125 Phenelzine Tablets, B.P. . With the written authority of the
Permanent Head-
Depressive illness resistant to
treatment with either tricyclic
antidepressants or electroconvulsive
therapy
Phobic states
126 Phenobarbitone Tablets,
B.P. . . . . . . . . . . . Epilepsy
127 Phenobarbitone B.P. . . . . Epilepsy
128 Phenobarbitone Sodium B.P. Epilepsy
129 Phenoxybenzamine Capsules
B.P. . . . . . . . . . . . With the written authority of the
Permanent Head-
Neurogenic urinary retention
Phaeochromocytoma
130 Pizotifen Malate . . . . . Prevention of migraine
131 Polyestradiol Phosphate . . Carcinoma of the breast
Carcinoma of the prostate
132 Polyisobutylene . . . . . . Ileostomy or colostomy conditions
133 Polyvinylpyrrolidone and
Vinyl Acetate Copolymer Ileostomy or colostomy conditions
134 Potassium Bicarbonate
Effervescent Tablets With the written authority of the
Permanent Head-
Hyperchloraemic hypokalaemic acidosis
135 (1) Prednisolone Acetate
Injection Local intra-articular or
peri-articular
infiltration
(2) Prednisolone
Tertiarybutylacetate
Injection
136 Prednisolone Acetate with
Phenylephrine
Hydrochloride, B.P. . Corneal grafts
Uveitis
137 Prednisolone Sodium
Phosphate Retention Enema
and Suppository Ulcerative colitis
Proctitis
138 "PREGESTIMIL" . . . . . . With the written authority of the
Permanent Head-
Cystic fibrosis
Enterokinase deficiency
Patients who are intolerant of both milk protein and soya protein
139 Propantheline Tablets, B.P. With the written authority of the
Permanent Head-
Chronic neuorgenic incontinence of
urine 140 Propranolol Tablets, B.P.,
160 mg . . . . . . . . . . Hypertension where there is an
inadequate response to a daily dose of at least 160
mg of propranolol
Frequent disabling angina without
evidence of cardiac failure where there
is an inadequate response to a daily dose of at least 160 mg of propranolol
141 "PROSOBEE" . . . . . . . With the written authority of the
Permanent Head-
Cows' milk allergy in children who have
not attained the age of 2 years
Galactosaemia
Homocystinuria
Lactose intolerance
142 Pyridoxine Hydrochloride
Tablets . . . . . . . . . . Anaemia proved to be responsive to
pyridoxine
Convulsions responsive to pyridoxine
Homocystinuria
Primary hyperoxaluria
Radiation sickness
Sideroblastic (refractory) anaemia
Treatment and prophylaxis of peripheral
neuritis caused or likely to be caused by isoniazid therapy
143 Pyrimethamine, B.P., with
Dapsone, B.P. Prophylaxis of chloroquine-resistant
falciparum malaria only
144 Pyrimethamine, B.P., with
Sulfadoxine Prophylaxis or treatment of
chloroquine-resistant falciparum malaria
only
145 Riboflavine Tablets . . . . Any disease or condition in a
pensioner
146 Sodium
Carboxymethylcellulose with
Pectin and Gelatin Ileostomy or colostomy conditions
147 Sodium Cromoglycate, B.P. . With the written authority of the
Permanent Head-
Allergic rhinitis not responding to
other treatment
148 Sodium Cromoglycate
Cartridges, B.P. Prophylaxis of bronchial asthma
149 Sodium Fusidate . . . . . . Any disease or condition in a patient
receiving treatment in or at an approved
hospital
With the written authority of the
Permanent Head-
For use in combination with another
antibiotic in the treatment of serious
staphylococcal infections confirmed by
bacteriological evidence
150 Sodium Valproate . . . . . Epilepsy
151 "SOYALAC" . . . . . . . . With the written authority of the
Permanent Head-
Cows' milk allergy in children who have
not attained the age of 2 years
Galactosaemia
Homocystinuria
Lactose intolerance
152 Spironolactone Tablets,
B.P. . . . . . . . . . . . With the written authority of the
Permanent Head-
Primary hyperaldosteronism
Secondary hyperaldosteronism
153 Sterculia . . . . . . . . . Ileostomy or colostomy conditions
154 Sulindac . . . . . . . . . With the written authority of the
Permanent Head-
Chronic rheumatoid arthritis not
responding to other non-steroidal
anti-flammatory drugs (disregarding
phenylbutazone)
155 (1) Surgical Cement . . . Any disease or condition in a
paraplegic
or quadriplegic patient
(2) Surgical Cement
Solvent
For use with surgical appliances
Ileostomy or colostomy conditions
156 (1) Testosterone Enanthate Carcinoma of the breast
(2) Testosterone
Propionate Injection, B.P. Hypogonadism
Klinefelter's syndrome (seminiferous
tubule dysgenesis)
157 (1) Testosterone
Propionate, B.P., with
Testosterone
Phenylpropionate, B.P. and
Testosterone Isocaproate Carcinoma of the breast
Gigantism
Hypogonadism
Klinefelter's syndrome (seminiferous
tubule dysgenesis)
(2) Testosterone
Propionate, B.P., with
Testosterone
Phenylpropionate, B.P.,
Testosterone Isocaproate
and Testosterone Decanoate
158 Tetracosactrin Zinc
Injection, B.P. . . . . . . With the written authority of the
Permanent Head-
Hypsarrhythmia
Multiple sclerosis, acute exacerbation
Status asthmaticus
Treatment of children who need long-term corticosteroid therapy but who are in
danger of growth suppression as a result
Treatment of patients who are being
withdrawn from long-term corticosteroid
therapy
Ulcerative colitis, proven, not
responding to parental corticosteroids
159 Thiamine Hydrochloride
Tablets, B.P. Any disease or condition in a
pensioner
160 Thiopropazate Hydrochloride Chorea
Drug induced dystonias
161 (1) Thioridazine
Hydrochloride, B.P. Chorea
Hyperactive states or organic or toxic
delirium
(2) Thioridazine Tablets,
B.P. . . . . . . . . . . . Major psychoses including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who
have not attained the age of 16 years
162 Timolol Maleate Eye Drops . Open angle glaucoma
163 Tobramycin Sulphate . . . . With the written authority of the
Permanent Head-
Infections where positive
bacteriological evidence confirms that
tobramycin sulphate is the most
appropriate antibiotic
Septicaemia, suspected or proven
164 Tranylcypromine Tablets,
B.P. . . . . . . . . . . . With the written authority of the
Permanent Head-
Depressive illness resistant to
treatment with either tricyclic
antidepressants or electroconvulsive
therapy
Phobic states
165 Triamcinolone Acetonide
Injection . . . . . . . . . Alopecia areata
Granulomata, dermal
, Keloid
Lichen plamus hypertrophic
Lichen simplex chronicus
Lupus erythematosus, chronic discoid
Necrobiosis lipoidica
Psoriasis
166 (1) Trifluoperazine
Hydrochloride B.P. Chorea
Hyperactive states of organic or toxic
delirium
(2) Trifluoperazine
Tablets, B.P. . . . . . . . Major psychoses including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who
have not attained the age of 16 years
167 Triglycerides Oil, Medium
Chain . . . . . . . . . . . With the written authority of the
Permanent Head-
Abetalipoproteinaemia, acanthocytosis
Intestinal lymphangiectasia
Patients requiring a ketogenic diet for
intractable childhood epilepsy
Severe hyperlipidaemia associated with
abdominal pain and requiring a minimal
fat intake
Steatorrhoea due to extensive small
bowel resection
168 "TRIGLYDE" . . . . . . . With the written authority of the
Permanent Head-
Patients requiring a ketogenic diet for
intractable childhood epilepsy
Proven malabsorption
169 Trioxysalen . . . . . . . . Vitiligo
170 Vancomycin Hydrochloride . Any disease or condition in a patient
receiving treatment in a hospital
Endophthalmitis
171 Verapamil Hydrochloride
Injection Cardiac arrhythmias
172 Verapamil Hydrochloride
Tablets Angina
Cardiac arrhythmias
173 Vidarabine . . . . . . . . Eye infections caused by Herpes
Simplex
Virus or by Vaccinia Virus where
idoxuridine has proved ineffective
174 "ZERODOR" . . . . . . . . Ileostomy or colostomy conditions 175
"ZOFF" . . . . . . . . . Any disease or condition in a paraplegic or
quadriplegic patient
For use with surgical appliances
Ileostomy or colostomy conditions
------------------------------------------------------------------------------
--
AustLII: Copyright Policy
| Disclaimers
| Privacy Policy
| Feedback